LMAT — Lemaitre Vascular Balance Sheet
0.000.00%
- $2.07bn
- $1.94bn
- $219.86m
- 96
- 11
- 78
- 65
Annual balance sheet for Lemaitre Vascular, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 27 | 70 | 82.7 | 105 | 300 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19.6 | 19.6 | 22 | 25.1 | 30.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 94.3 | 140 | 162 | 195 | 402 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 31.1 | 32.1 | 33.5 | 39.8 | 41.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 253 | 293 | 310 | 347 | 552 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 25.1 | 21.8 | 25.3 | 29.9 | 30.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 80.2 | 38.7 | 42.3 | 48.9 | 215 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 173 | 254 | 268 | 298 | 337 |
Total Liabilities & Shareholders' Equity | 253 | 293 | 310 | 347 | 552 |
Total Common Shares Outstanding |